Contents

Current Pharmaceutical Design, Volume 14 - Number 11

Editorial [Hot Topic: Anti-Cancer Drugs Executive Editor: Elke Bergmann-Leitner]

, 14(11): 1048

Elke Bergmann-Leitner


DOI: 10.2174/138161208784246207




Arginine Deprivation as a Targeted Therapy for Cancer

, 14(11): 1049 - 1057

L. Feun, M. You, C. J. Wu, M. T. Kuo, M. Wangpaichitr, S. Spector and N. Savaraj


DOI: 10.2174/138161208784246199




Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives

, 14(11): 1058 - 1077

Snezana K. Bjelogrlic, Sinisa Radulovic and Nada Babovic


DOI: 10.2174/138161208784246252




Design, Synthesis and Development of Novel Camptothecin Drugs

, 14(11): 1078 - 1097

Siong Tern Liew and Li-Xi Yang


DOI: 10.2174/138161208784246180




Combinatorial Application of Nucleic Acid-Based Agents Targeting Protein Kinases for Cancer Treatment

, 14(11): 1098 - 1112

B. Spankuch and K. Strebhardt


DOI: 10.2174/138161208784246243




Chemosensitization of Cancer by Nitric Oxide

, 14(11): 1113 - 1123

Richard Sullivan and Charles H. Graham


DOI: 10.2174/138161208784246225




Novel Approaches to Deliver Gemcitabine to Cancers

, 14(11): 1124 - 1137

L. Harivardhan Reddy and Patrick Couvreur


DOI: 10.2174/138161208784246216




Locked Nucleic Acid Holds Promise in the Treatment of Cancer

, 14(11): 1138 - 1142

Miriam Frieden and Henrik Orum


DOI: 10.2174/138161208784246234




Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy

, 14(11): 1143 - 1150

J. Stankova, A. K. Lawrance and R. Rozen


DOI: 10.2174/138161208784246171




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science